Keywords: isis, pharma, ciba, begin, antisense, cancer, drug

Isis Pharma and Ciba begin antisense cancer drug trial

Article | 29 January 1996

Print This

- Isis Pharmaceuticals and Ciba have begun clinical trials of its new antisense anticancer compound ISIS3521/CGP 64128A, a drug which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in